This thread is about alpha-gal syndrome (AGS) - meat allergy induced by tick bites. I’ve been living with AGS for >2 yrs. I hope this info will help those who suffer from this illness without knowing the cause. Please help bring awareness to #AGS (1/n)
I live in New England USA, surrounded by beautiful nature. This nature is rich in wildlife - animals and arthropods including many species of ticks. (2/n)
Ticks are infamous for the many infectious agents they carry that cause diseases such as
But this thread is about allergy caused by tick bites known as alpha-gal syndrome. Alpha-gal (galactose-α-1,3-galactose) is a sugar molecule found in all mammals except in Old World monkeys, apes & humans. This molecule is foreign to us humans. (4/n)
Certain types of ticks (such as lone star ticks) carry alpha-gal-containing antigens in their saliva. Once injected into the skin, these antigens are thought to induce robust IgE responses against the alpha-gal molecule. (5/n)
People bitten by these ticks can develop IgE against alpha-gal, which causes allergy to meat that contains it (beef, pork, lamb…etc). Unlike other food allergies which are immediate, alpha-gal symptoms appear 3-6 hours after meat consumption. (6/n) cdc.gov/ticks/alpha-ga…
The symptoms and severity vary between those with AGS. AGS reactions can include:
Rash
Hives
Nausea or vomiting
Difficulty breathing
Drop in blood pressure
Dizziness or faintness
Severe stomach pain
Anaphylaxis (requires EpiPen)
(7/n)
Alpha gal is also present in other mammalian-based products including medications, cosmetics, vaccines, gelatin, and milk products 🍦. Even biologics like cetuximab (a chimeric antibody containing alpha-gal within mouse portion) can induce reaction. (8/n)
In fact, it was the allergic reaction to cetuximab in patients that led Dr. Thomas Platts-Mills of @UVA to the discovery of IgE against alpha-gal and eventually linking it back to Lone Star ticks. (9/n)
Not all antibodies to alpha-gal are bad. In fact IgM against alpha gal elicited by gut microbiota is protective against Malaria. Plasmodium sporozoite expresses alpha gal and is bound and killed by such antibodies.
While it is a growing epidemic, there is still lack of awareness about the alpha-gal syndrome leading to delay in diagnosis and misdiagnosis. This is a great website to explore more. (11/n)
Finally, AGS has taken a toll on me, though I try to avoid all meats and meat-based products. Eating out is a huge risk. It only takes a trace of contaminant to make me very sick. Traveling has become a huge challenge for me 😢 #AvoidTicks (end)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Latest preprint by @tianyangmao et al shows that a stem-loop RNA RIG-I agonist in mice can
1) Block viral replication and disease when given early after SARS-CoV-2 infection (including VOCs)
2)Eliminate chronic infection in immunodeficient mice
We urgently need antiviral agents that can work against any viral threats. Here, we use a stem-loop RNA developed by @AnnaPyle to trigger interferon to stimulate antiviral state. Work by @MelissaLV14 et al demonstrated robust ISG induction in mice👇🏽 (2/)
First, we wanted to know if SLR can be used as a post-exposure prophylaxis. Mice infected with lethal dose of SARS-CoV-2 were treated with SLR 4 hours after exposure. SLR-treated mice had no detectable infectious virus 5 days later and most survived. (3/)
It’s finally happening! I will be giving a talk today at the #AAI2021 with Dr. Fauci and Dr. Saif in the session, COVID-19 and the Science of Pandemics (12-2PM ET).
My talk will be on “Protective vs. harmful immune responses in COVID-19”. See you there!
Amazing to listen to Dr. Fauci talk about the decades of basic research that led to the success of COVID vaccines. #AAI2021
“Effectiveness of the vaccines in real world setting is stunning - in every single age group.”
Exciting talk by Dr. Saif focuses on all things mucosal immunity! Secretory IgA, tissue-resident memory B cells and T cells are key to confer durable mucosal immunity. #AAI2021
SARS-CoV-2 infects not only respiratory mucosa, but also found in the gut, eyes and oral cavity.
This study will examine how vaccines might improve the symptoms of #LongCovid. We are recruiting people with long covid (PCR+, Ab+, T-test+, or COVID diagnosed by medical doctor) who live in Connecticut, >18 years old, and have not received vaccines yet but are planning to. (2/n)
To participate in this study, you will be asked to complete 4 online surveys and provide blood and saliva 3 times at sites in New Haven Connecticut. If you are interested in participating, please email covidrecovery@yale.edu (3/n)
New study by @MHitchingsEpi et al shows that an inactivated vaccine CoronaVac is effective against COVID-19 in a setting of epidemic P.1 variant transmission in Brazil 🇧🇷. A thread. (1/n)
The authors conducted a matched test-negative case-control study to estimate the effectiveness of an
inactivated vaccine, CoronaVac, in healthcare workers in Manaus, where P.1 accounted for ~75% of the circulating virus.(2/n)
Vaccination with at least one dose was associated with an adjusted vaccine effectiveness of 49.6% (95% CI, 11.3 - 71.4) against symptomatic SARSCoV-2 infection >14 days after receiving the first dose. (3/n)
An important thread from @PutrinoLab about why we should not be excluding PCR/Ab negative #LongCovid from analysis. So proud of @PutrinoLab for refusing to succumb to reviewers’ demand -which would have resulted in exclusion of data from underrepresented minorities. (1/)
I wish to highlight the importance of their study in this short thread and why I think it should be published ASAP. 84 people with long covid were examined for various symptoms in a retrospective cross-sectional observational study.(2/)
First, look at the demographic data of those with #LongCovid. Compared to acute severe COVID (in older adults, male>female), long haulers appear more skewed towards women of younger age. (3/)
To address this question, we first looked at other confirmed cases of COVID reinfection. The number of such cases is limited due to the requirement for viral genome sequences in both infections. (2/)
We noted that very little information is available regarding the immune responses that developed during the first infection that can explain why someone would get reinfected. (3/)